Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

被引：0
|
作者：
Claudia Marchetti
Francesca De Felice
Innocenza Palaia
Giorgia Perniola
Angela Musella
Daniela Musio
Ludovico Muzii
Vincenzo Tombolini
Pierluigi Benedetti Panici
机构：
[1] University of Rome 2“Sapienza”,Department of Gynecological and Obstetrical Sciences and Urological Sciences
[2] Policlinico Umberto I “Sapienza” University of Rome,Department of Radiotherapy
来源：
BMC Women's Health | / 14卷
关键词：
Risk-reducing salpingo-oophorectomy; Prophylactic; BRCA; Ovarian cancer; Cause; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
    Susan M. Domchek
    Tara M. Friebel
    Judy E. Garber
    Claudine Isaacs
    Ellen Matloff
    Rosalind Eeles
    D. Gareth Evans
    Wendy Rubinstein
    Christian F. Singer
    Stephen Rubin
    Henry T. Lynch
    Mary B. Daly
    Jeffrey Weitzel
    Patricia A. Ganz
    Gabriella Pichert
    Olufunmilayo I. Olopade
    Gail Tomlinson
    Nadine Tung
    Joanne L. Blum
    Fergus Couch
    Timothy R. Rebbeck
    Breast Cancer Research and Treatment, 2010, 124 : 195 - 203
  • [32] Occult ovarian cancers at the time of risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
    Rebbeck, T. R.
    Friebel, T. M.
    Domchek, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] OUTCOMES OF INCIDENTALLY DETECTED OVARIAN CANCERS DIAGNOSED AT TIME OF RISK-REDUCING SALPINGO-OOPHORECTOMY IN BRCA MUTATION CARRIERS
    Cowan, R.
    Nobre, S. Pedra
    Zhou, Q.
    Iasonos, A.
    Roche, K. Long
    Gardner, G.
    Abu-Rustum, N.
    Aghajanian, C.
    Cadoo, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A22 - A22
  • [34] No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers
    van Bommel, Majke H. D.
    de Jong, Marieke Arts
    Steenbeek, Miranda P.
    Bots, Michiel L.
    van Westerop, Liselore L. M.
    Hopman, Maria T. E.
    Hoogerbrugge, Nicoline
    de Hullu, Joanne A.
    Maas, Angela H. E. M.
    JOURNAL OF CARDIOLOGY, 2021, 77 (06) : 570 - 575
  • [35] Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers
    Cowan, Renee
    Nobre, Silvana Pedra
    Pradhan, Nisha
    Yasukawa, Maya
    Zhou, Qin C.
    Iasonos, Alexia
    Soslow, Robert A.
    Arnold, Angela G.
    Trottier, Magan
    Catchings, Amanda
    Roche, Kara Long
    Gardner, Ginger
    Robson, Mark
    Abu Rustum, Nadeem R.
    Aghajanian, Carol
    Cadoo, Karen
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 521 - 526
  • [36] Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
    Garcia, Christine
    Lyon, Liisa
    Conell, Carol
    Littell, Ramey D.
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 723 - 726
  • [37] Surveillance and health outcomes for BRCA mutation carriers following risk-reducing salpingo-oophorectomy (RRSO)
    Prendergast, E.
    Green, M.
    Zakhour, M.
    Lester, J.
    Li, A.
    Walsh, C.
    Rimel, B. J.
    Leuchter, R.
    Karlan, B.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 188 - 189
  • [38] Impact of Risk-Reducing Salpingo-Oophorectomy on BRCA1/2 Female Carriers Diagnosed with Early Breast Cancer
    Meireles, P. Antunes
    Fragoso, S.
    Santos, S.
    Duarte, T.
    Lopez, B.
    Correia, L.
    Miguel, I.
    Rodrigues, P.
    Vaz, F.
    BREAST, 2025, 80
  • [39] Risk-Reducing Salpingo-Oophorectomy for BRCA Carriers: Is There a Benefit to Combined Breast Surgery?
    Liu, Cici
    Monier, Elizabeth
    Brady, Rachel
    Kehoe, Siobhan
    OBSTETRICS AND GYNECOLOGY, 2016, 127 : 138S - 138S
  • [40] Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
    Mavaddat, Nasim
    Antoniou, Antonis C.
    Mooij, Thea M.
    Hooning, Maartje J.
    Heemskerk-Gerritsen, Bernadette A.
    Nogues, Catherine
    Laborde, Lilian
    Breysse, Emmanuel
    Stoppa-Lyonnet, Dominique
    Gauthier-Villars, Marion
    Buecher, Bruno
    Caron, Olivier
    Fourme-Mouret, Emmanuelle
    Fricker, Jean-Pierre
    Lasset, Christine
    Bonadona, Valerie
    Berthet, Pascaline
    Faivre, Laurence
    Luporsi, Elisabeth
    Mari, Veronique
    Gladieff, Laurence
    Gesta, Paul
    Sobol, Hagay
    Eisinger, Francois
    Nogues, Catherine
    Longy, Michel
    Dugast, Catherine
    Colas, Chrystelle
    Coupier, Isabelle
    Pujol, Pascal
    Corsini, Carole
    Lortholary, Alain
    Vennin, Philippe
    Adenis, Claude
    Nguyen, Tan Dat
    Delnatte, Capucine
    Tinat, Julie
    Tennevet, Isabelle
    Limacher, Jean-Marc
    Maugard, Christine
    Bignon, Yves-Jean
    Demange, Liliane
    Penet, Clotilde
    Dreyfus, Helene
    Cohen-Haguenauer, Odile
    Venat-Bouvet, Laurence
    Leroux, Dominique
    Zattara-Cannoni, Helene
    Fert-Ferrer, Sandra
    Bera, Odile
    BREAST CANCER RESEARCH, 2020, 22 (01)
12345